Michael Polark
Stock Analyst at Wolfe Research
(3.85)
# 1,963
Out of 4,673 analysts
178
Total ratings
51.4%
Success rate
6.6%
Average return
Main Sectors:
Stocks Rated by Michael Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Upgraded: Buy | $130 | $116.64 | +11.45% | 6 | Aug 13, 2026 | |
| A Agilent Technologies | Initiated Coverage: Hold | $135 | $159.00 | -15.09% | 1 | Jun 1, 2026 | |
| BRKR Bruker | Downgraded: Hold | n/a | $59.56 | - | 1 | Jun 1, 2026 | |
| DHR Danaher | Downgraded: Hold | n/a | $218.85 | - | 1 | Jun 1, 2026 | |
| MTD Mettler-Toledo International | Initiated Coverage: Hold | $1,180 | $1,395.25 | -15.43% | 1 | Jun 1, 2026 | |
| RVTY Revvity | Initiated Coverage: Hold | n/a | $124.75 | - | 1 | Jun 1, 2026 | |
| RGEN Repligen | Initiated Coverage: Buy | $145 | $181.13 | -19.95% | 1 | Jun 1, 2026 | |
| TMO Thermo Fisher Scientific | Initiated Coverage: Buy | $535 | $629.27 | -14.98% | 1 | Jun 1, 2026 | |
| WAT Waters | Maintained: Buy | $425 | $410.70 | +3.48% | 1 | Jun 1, 2026 | |
| WST West Pharmaceutical Services | Rated: Buy | $375 | $353.08 | +6.21% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $7 | $14.46 | -51.59% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $22.60 | -7.08% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $26.27 | - | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $50.37 | - | 6 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.60 | - | 5 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $92 | $89.79 | +2.46% | 8 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $62.36 | - | 15 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $47 | $34.26 | +37.19% | 1 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $93.35 | - | 6 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $13 | $14.03 | n/a | 11 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $245 → $270 | $237.93 | n/a | 17 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $17 | $19.57 | n/a | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $19.05 | n/a | 1 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $60 | $78.74 | n/a | 19 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $350 | $148.16 | n/a | 4 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $26.99 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $180 | $231.52 | n/a | 14 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $405 | $329.45 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $100.98 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $115 | $128.52 | n/a | 19 | Jun 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $5.23 | n/a | 1 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $121 → $140 | $92.34 | n/a | 2 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $138.83 | n/a | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $22.32 | n/a | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $315 | $378.81 | n/a | 9 | Apr 5, 2022 |
Abbott Laboratories
Aug 13, 2026
Upgraded: Buy
Price Target: $130
Current: $116.64
Upside: +11.45%
Agilent Technologies
Jun 1, 2026
Initiated Coverage: Hold
Price Target: $135
Current: $159.00
Upside: -15.09%
Bruker
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $59.56
Upside: -
Danaher
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $218.85
Upside: -
Mettler-Toledo International
Jun 1, 2026
Initiated Coverage: Hold
Price Target: $1,180
Current: $1,395.25
Upside: -15.43%
Revvity
Jun 1, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $124.75
Upside: -
Repligen
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $145
Current: $181.13
Upside: -19.95%
Thermo Fisher Scientific
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $535
Current: $629.27
Upside: -14.98%
Waters
Jun 1, 2026
Maintained: Buy
Price Target: $425
Current: $410.70
Upside: +3.48%
West Pharmaceutical Services
Jun 1, 2026
Rated: Buy
Price Target: $375
Current: $353.08
Upside: +6.21%
Jun 1, 2026
Rated: Sell
Price Target: $7
Current: $14.46
Upside: -51.59%
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $22.60
Upside: -7.08%
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $26.27
Upside: -
May 29, 2026
Downgraded: Hold
Price Target: n/a
Current: $50.37
Upside: -
May 13, 2026
Maintained: Hold
Price Target: n/a
Current: $1.60
Upside: -
Apr 1, 2026
Upgraded: Buy
Price Target: $92
Current: $89.79
Upside: +2.46%
Feb 13, 2026
Downgraded: Hold
Price Target: n/a
Current: $62.36
Upside: -
Jan 12, 2026
Initiated Coverage: Buy
Price Target: $47
Current: $34.26
Upside: +37.19%
Aug 25, 2025
Reiterated: Hold
Price Target: n/a
Current: $93.35
Upside: -
Aug 14, 2025
Maintained: Buy
Price Target: $14 → $13
Current: $14.03
Upside: n/a
Aug 8, 2025
Maintained: Buy
Price Target: $245 → $270
Current: $237.93
Upside: n/a
Aug 8, 2025
Maintained: Buy
Price Target: $19 → $17
Current: $19.57
Upside: n/a
May 29, 2025
Initiated Coverage: Buy
Price Target: $20
Current: $19.05
Upside: n/a
May 19, 2025
Upgraded: Buy
Price Target: $60
Current: $78.74
Upside: n/a
May 12, 2025
Upgraded: Buy
Price Target: $350
Current: $148.16
Upside: n/a
Mar 31, 2025
Initiated Coverage: Buy
Price Target: $29
Current: $26.99
Upside: n/a
Sep 17, 2024
Downgraded: Sell
Price Target: $180
Current: $231.52
Upside: n/a
Sep 9, 2024
Initiated Coverage: Buy
Price Target: $405
Current: $329.45
Upside: n/a
Sep 9, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $100.98
Upside: n/a
Jun 19, 2024
Upgraded: Buy
Price Target: $115
Current: $128.52
Upside: n/a
Oct 19, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $5.23
Upside: n/a
Jul 28, 2023
Maintained: Buy
Price Target: $121 → $140
Current: $92.34
Upside: n/a
Apr 25, 2023
Downgraded: Hold
Price Target: n/a
Current: $138.83
Upside: n/a
Jan 26, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $22.32
Upside: n/a
Apr 5, 2022
Initiated Coverage: Hold
Price Target: $315
Current: $378.81
Upside: n/a